← FDA DRUG APPROVALS

FDA ANDA · ANDA215984

VALBENAZINE TOSYLATE

Sponsor: TEVA PHARMS INC

APPLICATION
ANDA215984
TYPE
ANDA
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
None (Tentative Approval)

Products

VALBENAZINE TOSYLATENone (Tentative Approval)
VALBENAZINE TOSYLATE 80MG · CAPSULE · ORAL
VALBENAZINE TOSYLATENone (Tentative Approval)
VALBENAZINE TOSYLATE 40MG · CAPSULE · ORAL

Approval history

2026-01-21UNKNOWN · Original · standardLetterTA
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →